Search for your doctor or find doctors accepting new patients.
Find out about our hospital visiting hours and policies.
Log In to MyUCSDChart to access your medical information
Find out about our academic nursing program.
Fibrinogen, a blood-clotting protein found in circulating blood, has been found to inhibit the growth of central nervous system
neuronal cells, a process that is necessary for the regeneration of the spinal cord after traumatic injury. The findings by researchers at the University of California, San Diego (UCSD) School of Medicine, may explain why the human body is unable to repair itself after most spinal cord injuries.
The research team studied three types of spinal cord injuries in mice and rats which resulted in cellular and vascular damage, and leakage of fibrinogen from the blood vessels. Once injured, neurons cannot be repaired because of various inhibitors that are present in the brain and the spinal cord after damage, which results in a patient’s paralysis. The researchers were surprised at the massive deposits of fibrinogen found at the sites of injury. That discovery led them to investigate the protein’s effect on neuronal cells’ ability to regenerate.
“Our study shows that fibrinogen directly affects neurons by inhibiting their ability for repair,” said Akassoglou. Fibrinogen – contained in the blood which leaks at the site of injury – begins the process of inhibiting axonal growth by binding to the beta 3 integrin receptor. This binding, in turn, induces the activation of another receptor on the neuronal cells, called the epidermal growth factor receptor. When the second receptor is activated, it inhibits the axonal growth. Other inhibitors have been identified that use the same epidermal growth factor receptor, but this is the first blood-derived inhibitor that has been found.
The discovery may open the door to a possible strategy to improving recovery after spinal cord injury by discovering a way to block activation of neuronal receptors by fibrinogen.
Identifying the specific inhibitors that impede the repair process could provide ways to regenerate and connect the damaged nerves and initiate recovery from paralysis after spinal cord injury.
“Inhibiting the damaging effects of fibrinogen on neurons may potentially facilitate repair in the nervous system after injury” said Akassoglou. A similar mechanism could be at work in other neurological diseases that result in paralysis, such as multiple sclerosis or hemorrhagic stroke, where blood vessels break and bleed into the brain. She added that such a therapeutic approach wouldn’t interfere with fibrinogen’s essential role in coagulation, because its blood-clotting mechanism depends on binding with a different receptor.
Additional contributors to the paper include first author Christian Schachtrup, Jerry Lu and Ben D. Sachs of UCSD’s Department of Pharmacology, and Paul Lu, Jae K. Lee and Binhai Zheng of UCSD’s Department of Neurosciences. The research was funded in part by grants from the German Research Foundation, National Multiple Sclerosis Society, National Institute of Neurologic Diseases and Stroke (NIH/NINDS) and the Christopher Reeve and Sam Schmidt Paralysis Foundation.
# # #
Media Contact: Debra Kain, 619-543-6163
UCSD Department of Pharmacology
Katerina Akassoglou, PhD
Binhai Zheng, PhD
Official Web Site of the University of California, San Diego.